Management of Congenital Heart Disease: State of the Art; Part I—ACYANOTIC Heart Defects
AbstractSince the description of surgery for patent ductus arteriosus in late 1930s, an innumerable number of advances have taken place in the management of congenital heart defects (CHDs). In this review the current status of treatment of seven of the most common acyanotic CHDs was reviewed. The discussion included indications for, and timing of, intervention and methods of intervention. The indications are, by and large, determined by the severity of the lesion. Pressure gradients in obstructive lesions and the magnitude of the shunt in left-to-right shunt lesions are used to assess the severity of the lesion. The timing of intervention is different for each lesion and largely dependent upon when the criteria for indications for intervention were met. Appropriate medical management is necessary in most patients. Trans-catheter methods are preferable in some defects while surgery is a better option in some other defects. The currently available medical, trans-catheter, and surgical methods to treat acyanotic CHD are feasible, safe, and effective. View Full-Text
Share & Cite This Article
Rao, P.S. Management of Congenital Heart Disease: State of the Art; Part I—ACYANOTIC Heart Defects. Children 2019, 6, 42.
Rao PS. Management of Congenital Heart Disease: State of the Art; Part I—ACYANOTIC Heart Defects. Children. 2019; 6(3):42.Chicago/Turabian Style
Rao, P. Syamasundar . 2019. "Management of Congenital Heart Disease: State of the Art; Part I—ACYANOTIC Heart Defects." Children 6, no. 3: 42.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.